The FDA said yesterday that it awarded 21 clinical trial research grants totaling more than $23 million over the next 4 years to stimulate product development for patients with rare diseases.
The Orphan Products Clinical Trials Grants Program has awarded more than $370 million to fund more than 590 clinical studies since its creation in 1983, according to the federal watchdog. The grants are intended to fund clinical studies examining products that could substantially contribute to the FDA approval of products for use in rare diseases.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA awards product development grants for rare diseases appeared first on MassDevice.
from MassDevice http://ift.tt/2ervCv6
Cap comentari:
Publica un comentari a l'entrada